Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New cell adhesion inhibitors from Shionogi

Feb. 19, 1998

Centocor to acquire rights to reteplase in U.S., Canada

Feb. 18, 1998

Tsetse thrombin inhibitor isolated, purified and characterized at Yale

Feb. 18, 1998

Canadian market introduction for Fraxiparine announced

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Anticoagulant apoB-100 fragment discovered at Royal Free Hospital

Feb. 6, 1998

TIMI 12 trial results published

Feb. 4, 1998

Lactoferrin use in heparin neutralization described

Feb. 3, 1998

Antithrombotic agents in stroke indications

Feb. 2, 1998

FDA advisory committee recommends Integrilin approval

Jan. 29, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...